Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

BKV Infection · EBV Infection · CMV Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Catholic University of Korea Seoul St.Mary's Hospital, Seoul, South Korea
Contact: Principal Investigator (Dong-Gun Lee, MD-PhD)

Study leads

Dong-Gun Lee, MD-PhD
Principal Investigator
Department of Infectious Disease, The Catholic University of Korea Seoul St.Mary's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

BKV Infection · CMV Infection · EBV Infection

Abroad (travel likely)Recruiting

Seoul, South Korea

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Pathogen Infection · EBV Infection · CMV Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China